NCT06544369

Brief Summary

the aim of the study is to compare the severity of symptoms in case of reinfection with COVID-19. the study will compare between two groups; vaccinated and non vaccinated. the side effects from vaccination and symptoms of infection and reinfection will be reprted.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2021

Completed
26 days until next milestone

Study Start

First participant enrolled

November 20, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 18, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 18, 2022

Completed
2.6 years until next milestone

First Posted

Study publicly available on registry

August 9, 2024

Completed
Last Updated

August 9, 2024

Status Verified

August 1, 2024

Enrollment Period

2 months

First QC Date

October 25, 2021

Last Update Submit

August 6, 2024

Conditions

COVID-19 Pandemic

Outcome Measures

Primary Outcomes (1)

  • percent of reinfection with COVID-19 in vaccinated and non vaccinated

    one year

Secondary Outcomes (1)

  • scoring of symptoms in case of reinfection in vaccinated and non vaccinated

    one year

Study Arms (2)

Vaccinated group

all criteria are accepted for study

Biological: COVID-19 vaccin

Non-vaccinated group

all criteria are accepted for study

Biological: COVID-19 vaccin

Interventions

COVID-19 vaccinBIOLOGICAL

injection

Non-vaccinated groupVaccinated group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

the study group are infected patients with COVID-19

You may qualify if:

  • clinically diagnosed with COVID infection
  • take any type of vaccines

You may not qualify if:

  • no accept sharing
  • not vaccinated with COVID vaccine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Deraya university

Minya, 05673, Egypt

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
lecturer of pharmaceutics and clinical pharmacy Deraya university

Study Record Dates

First Submitted

October 25, 2021

First Posted

August 9, 2024

Study Start

November 20, 2021

Primary Completion

January 18, 2022

Study Completion

January 18, 2022

Last Updated

August 9, 2024

Record last verified: 2024-08

Locations

EG(1)